EnWave Confirms Availability of Moon Cheese(R) at 3,400 Store Locations of a Major American Coffee Retailer

VANCOUVER, BC--(Marketwired - July 07, 2015) - EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company") is pleased to confirm the launch of Cheddar and Gouda Moon Cheese^® in approximately 3,400 stores of a Major American Coffee Retailer ("MCR"). Moon Cheese^® will participate in a sixteen week product showcase program. During the first nine weeks of this program, specific in-store marketing efforts will be implemented to highlight the Moon Cheese^® at the point of purchase. The following seven weeks will be used to collect pertinent data to determine whether continued sales levels justify longer term and potentially increased distribution.

Moon Cheese^® is currently selling through an extensive list of major and regional grocery store chains including the Overwaitea Group, Sobeys and Metro in Canada, and select banners of the Kroger Company and REI locations in the United States. The availability of Moon Cheese^® at MCR will provide more consumers with the opportunity to experience and enjoy this 100% natural and delicious cheese snack product.

Moon Cheese^® is exclusively produced by NutraDried LLP ("NutraDried"), a food processing subsidiary of EnWave located in Washington State. NutraDried uses EnWave's patented Radiant Energy Vacuum ("REV^™") dehydration technology to efficiently and gently dry several healthy snack products.

About EnWave
EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV^™) dehydration technology. EnWave aims to sign royalty-bearing commercial licenses with leading food and pharmaceutical companies for the use of its revolutionary technology. Thus far the Company has signed thirteen royalty-bearing licenses, opening up eight distinct market sectors for commercialization with companies.

EnWave is introducing REV^™ as a new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV^™ platforms: nutraREV^® is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour; powderREV^® is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point and quantaREV^® is used for continuous, high-volume low-temperature drying. Two additional platforms, bioREV^® and freezeREV^®, are being developed as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation
Dr. Tim Durance
President, CEO and Director

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.